Free provider profile
WILLIAM UPSHAW, M.D.
NPI 1932276425
Individual
Psychiatry & Neurology, Psychiatry
Active registration
Save to rep workspaceNPI registry Registry record
Source: CMS NPPES registry, updated continuously. This record was last updated 2025-06-13.
1001 S MACDILL AVE STE 400, TAMPA, FL, 33629
813-731-5807
3 practice locations listed
Enumerated 2006-11-29
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — 3 practice locations listed — multi-site footprint.
- — 2 taxonomies listed — broader service mix.
- — Record updated within the last three years.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
262
Medicare patients
31
Part D drug cost
$158,378
Brand-name share
48.5%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Spravato (Esketamine Hcl) | 118 | $154,942 |
| Lorazepam (Lorazepam) | 12 | $172 |
| Methylphenidate Hcl (Methylphenidate Hcl) | 12 | $148 |
| Bupropion Xl (Bupropion Hcl) | 13 | $91 |
| Lithium Carbonate Er (Lithium Carbonate) | 12 | $54 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Spravato (esketamine) Medicare billing
Source: CMS Medicare Part B fee-for-service, HCPCS G2082/G2083.
2024142 sessions · 14 patients · $125,467
2023165 sessions · 12 patients · $143,946
Full Spravato label-compliance detail — sessions per patient against the FDA label, risk flags and year-over-year trend.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.